Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488

Expensive Star

Download real time

6473.00 -65.00 (-0.99%)

New 52W High in past week

169.8K NSE+BSE Volume

NSE 23 May, 2025 2:35 PM (IST)

1

Broker 1Year buys

1 active buys

1

Broker 1Year sells

1 active sells

6

Broker 1Year neutral

6 active holds

Divi's Laboratories Ltd. share price target

Divi's Laboratories Ltd. has an average share price target of 5832.12. The consensus estimate represents a downside of -9.90% from the last price of 6473. View 15 reports from 9 analysts offering long-term price targets for Divi's Laboratories Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	23 May 2025	Divi's Laboratories	Consensus Share Price Target	6473.00	6328.63	-	-2.23	hold	pdf Detailed Estimates
	21 May 2023	Divi's Laboratories	Prabhudas Lilladhar	6473.00	2700.00	3098.30 (108.92%)		Hold	pdf post cache		Broker Report DIVI'S LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	21 May 2023	Divi's Laboratories	ICICI Direct Reco Target	6473.00	3575.00	3098.30 (108.92%)	Target met	Buy	pdf post cache		Broker Report Divi's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	19 Mar 2023	Divi's Laboratories	Motilal Oswal	6473.00	2620.00	2791.50 (131.88%)		Neutral	pdf post cache		Broker Report Work-in-progress for a better outlook Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	06 Feb 2023	Divi's Laboratories	ICICI Securities Limited Target	6473.00	3024.00	2884.35 (124.42%)	Target met	Hold	pdf post cache		Broker Report Performance weakens, margins shrink ICICI Securities Limited Divi’s Laboratories’ (Divi’s) Q3FY23 performance was well below our estimates. Consolidated revenues fell 7.9% QoQ to Rs17.1bn (I-Sec: Rs20.5bn), EBITDA margin slipped to its lowest-ever at 23.9% (-2,010bps YoY, -960bpsQoQ) pdf Copy Link Share on Share on Share on Share on Alert
	05 Feb 2023	Divi's Laboratories	Prabhudas Lilladhar Target	6473.00	2700.00	2884.35 (124.42%)		Hold	pdf post cache		Broker Report DIVI'S LABORATORIES Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	04 Feb 2023	Divi's Laboratories	BOB Capital Markets Ltd. Target	6473.00	3200.00	2884.35 (124.42%)	Target met	Hold	pdf post cache		Broker Report Divi's Labs (HOLD): Big miss on revenue and margins BOB Capital Markets Ltd. Q3 disappoints as revenue/PAT of Rs 17bn/Rs 3bn missed consensus by 12%/38% pdf Copy Link Share on Share on Share on Share on Alert
	04 Feb 2023	Divi's Laboratories	Motilal Oswal Reco Target	6473.00	2620.00	2884.35 (124.42%)		Neutral	pdf post cache		Broker Report Lower realization in API sales/ reduced operating leverage drag earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	03 Feb 2023	Divi's Laboratories	ICICI Direct Target	6473.00	2945.00	2884.35 (124.42%)	Target met	Hold	pdf post cache		Broker Report Divi's Laboratories ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	11 Nov 2022	Divi's Laboratories	SMC online	6473.00		3271.40 (97.87%)		Results Update	pdf post cache		Broker Report Divis Laboratories Limited SMC online pdf Copy Link Share on Share on Share on Share on Alert
	09 Nov 2022	Divi's Laboratories	BOB Capital Markets Ltd. Target	6473.00	3450.00	3298.75 (96.23%)	Target met	Hold	pdf post cache		Broker Report Divi's Labs (HOLD): Disappointing quarter BOB Capital Markets Ltd. Q2 revenue fell 7% YoY to Rs 18.5bn, weighed down by a decline in custom synthesis business pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners